Barclays’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $330K | Sell |
195,473
-150,100
| -43% | -$267K | ﹤0.01% | 3424 |
|
|
2025
Q4 | $491K | Buy |
345,573
+52,381
| +18% | +$76.3K | ﹤0.01% | 3857 |
|
|
2025
Q3 | $481K | Sell |
293,192
-4,500
| -2% | -$5K | ﹤0.01% | 3838 |
|
|
2025
Q2 | $218K | Buy |
297,692
+66,702
| +29% | +$57.6K | ﹤0.01% | 4219 |
|
|
2025
Q1 | $186K | Sell |
230,990
-69,202
| -23% | -$79.6K | ﹤0.01% | 4082 |
|
|
2024
Q4 | $414K | Sell |
300,192
-2,166,113
| -88% | -$2.43M | ﹤0.01% | 3943 |
|
|
2024
Q3 | $2.56M | Buy |
2,466,305
+275,784
| +13% | +$378K | ﹤0.01% | 2646 |
|
|
2024
Q2 | $3.79M | Buy |
2,190,521
+125,170
| +6% | +$252K | ﹤0.01% | 1706 |
|
|
2024
Q1 | $4.94M | Sell |
2,065,351
-1,419,044
| -41% | -$3.49M | ﹤0.01% | 1865 |
|
|
2023
Q4 | $11.6M | Buy |
3,484,395
+1,108,838
| +47% | +$2.97M | ﹤0.01% | 1406 |
|
|
2023
Q3 | $8.88M | Buy |
2,375,557
+2,301,444
| +3,105% | +$10.6M | 0.01% | 1042 |
|
|
2023
Q2 | $316K | Sell |
74,113
-114,403
| -61% | -$675K | ﹤0.01% | 3010 |
|
|
2023
Q1 | $1.29M | Sell |
188,516
-110,490
| -37% | -$858K | ﹤0.01% | 2539 |
|
|
2022
Q4 | $2.37M | Buy |
299,006
+94,202
| +46% | +$725K | ﹤0.01% | 2141 |
|
|
2022
Q3 | $1.97M | Buy |
204,804
+162,448
| +384% | +$1.64M | ﹤0.01% | 1762 |
|
|
2022
Q2 | $308K | Sell |
42,356
-12,104
| -22% | -$105K | ﹤0.01% | 3178 |
|
|
2022
Q1 | $705K | Sell |
54,460
-42,230
| -44% | -$537K | ﹤0.01% | 2657 |
|
|
2021
Q4 | $1.54M | Sell |
96,690
-35,533
| -27% | -$621K | ﹤0.01% | 2537 |
|
|
2021
Q3 | $2.13M | Buy |
132,223
+24,757
| +23% | +$363K | ﹤0.01% | 2301 |
|
|
2021
Q2 | $1.49M | Sell |
107,466
-41,118
| -28% | -$582K | ﹤0.01% | 2395 |
|
|
2021
Q1 | $2.17M | Sell |
148,584
-494,432
| -77% | -$8.39M | ﹤0.01% | 2204 |
|
|
2020
Q4 | $11.2M | Buy |
643,016
+301,709
| +88% | +$5.37M | 0.01% | 1120 |
|
|
2020
Q3 | $6.26M | Buy |
341,307
+56,394
| +20% | +$1.05M | ﹤0.01% | 1270 |
|
|
2020
Q2 | $5.09M | Sell |
284,913
-124,055
| -30% | -$2.1M | ﹤0.01% | 1372 |
|
|
2020
Q1 | $6.63M | Buy |
408,968
+333,856
| +444% | +$6.17M | 0.01% | 1257 |
|
|
2019
Q4 | $1.35M | Sell |
75,112
-12,108
| -14% | -$223K | ﹤0.01% | 3395 |
|
|
2019
Q3 | $1.77M | Buy |
87,220
+47,315
| +119% | +$945K | ﹤0.01% | 3018 |
|
|
2019
Q2 | $882K | Buy |
39,905
+19,622
| +97% | +$341K | ﹤0.01% | 3815 |
|
|
2019
Q1 | $276K | Buy |
20,283
+17,687
| +681% | +$236K | ﹤0.01% | 4582 |
|
|
2018
Q4 | $23K | Sell |
2,596
-76,975
| -97% | -$891K | ﹤0.01% | 5835 |
|
|
2018
Q3 | $1.31M | Buy |
79,571
+56,954
| +252% | +$1.01M | ﹤0.01% | 3355 |
|
|
2018
Q2 | $317K | Buy |
22,617
+12,245
| +118% | +$175K | ﹤0.01% | 4337 |
|
|
2018
Q1 | $115K | Buy |
10,372
+2,793
| +37% | +$30.6K | ﹤0.01% | 5278 |
|
|
2017
Q4 | $67K | Sell |
7,579
-1,060
| -12% | -$11.3K | ﹤0.01% | 5544 |
|
|
2017
Q3 | $115K | Sell |
8,639
-13,008
| -60% | -$172K | ﹤0.01% | 4833 |
|
|
2017
Q2 | $311K | Buy |
21,647
+3,136
| +17% | +$60.3K | ﹤0.01% | 3965 |
|
|
2017
Q1 | $391K | Buy |
18,511
+16,302
| +738% | +$401K | ﹤0.01% | 3650 |
|
|
2016
Q4 | $62K | Sell |
2,209
-2,594
| -54% | -$72.6K | ﹤0.01% | 5025 |
|
|
2016
Q3 | $129K | Buy |
4,803
+4,186
| +678% | +$114K | ﹤0.01% | 4320 |
|
|
2016
Q2 | $10K | Buy |
617
+342
| +124% | +$6.42K | ﹤0.01% | 5531 |
|
|
2016
Q1 | $6K | Sell |
275
-443
| -62% | -$7.26K | ﹤0.01% | 5616 |
|
|
2015
Q4 | $16K | Buy |
718
+595
| +484% | +$15.3K | ﹤0.01% | 5257 |
|
|
2015
Q3 | $2K | Sell |
123
-329
| -73% | -$10K | ﹤0.01% | 6308 |
|
|
2015
Q2 | $13K | Buy |
452
+244
| +117% | +$6.17K | ﹤0.01% | 5930 |
|
|
2015
Q1 | $7K | Sell |
208
-180
| -46% | -$4.65K | ﹤0.01% | 6404 |
|
|
2014
Q4 | $6K | Buy |
+388
| New | +$5.47K | ﹤0.01% | 6919 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG